REVIEW
Accepted on 27 Jun 2025
CRISPR/Cas9 Technology in Tumor Research and Drug Development Application Progress and Future Prospects
doi 10.3389/fphar.2025.1552741
- 109 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- CRISPR/Cas9 in Cancer: Pioneering Gene Editing for Enhanced Drug Discovery
CRISPR/Cas9 in Cancer: Pioneering Gene Editing for Enhanced Drug Discovery
2,350
Total downloads
14k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 20 Sep 2024
A quantitative systems pharmacology (QSP) platform for preclinical to clinical translation of in-vivo CRISPR-Cas therapy
doi 10.3389/fphar.2024.1454785
- 3,654 views
- 1 citation
ORIGINAL RESEARCH
Published on 05 Dec 2019
Knockdown of PTGS2 by CRISPR/CAS9 System Designates a New Potential Gene Target for Melanoma Treatment
doi 10.3389/fphar.2019.01456
- 5,767 views
- 26 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Pharmacogenetics and Pharmacogenomics
Experimental Pharmacology and Drug Discovery
Participating Journals
Frontiers in Genetics
- 2.8 impact factor
- 6.2 citescore
Frontiers in Genome Editing
- 4.4 impact factor
- 9.5 citescore
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: